Mamas on Bedrest: The Latest in the Makena Debacle

November 7th, 2012

An update in the latest in the K-V Pharmaceuticals/Makena saga. Currently, K-V Pharmaceuticals has filed a lawsuit with the US International Trade Commission asking that they impose cease and desist orders on a number of compounding pharmaceutical companies who are distributing 17 HydroxyProgesterone (17P) injections for the prevention of preterm labor and preterm birth. K-V Pharmaceuticals won US FDA approval to distribute and market the injections as Makena in February 2011. Since that time, the company has been embroiled in a public relations nightmare after increasing the price from $10-$20 per injection to $1500 per injection. Now the company is pretty much the pariah of the pharmaceutical industry and obstetrical world and is in bankruptcy as well.

Leave a Reply

Your email address will not be published. Required fields are marked *